CAS: 263707-16-0
![3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-](https://static.cymitquimica.com/products/IN/thumb/DA002SX8.jpg)
3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-
CAS:263707-16-0
Formula:
C16H15ClN4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
330.7689
Ref: IN-DA002SX8
| 5mg | 35.00 € | ||
| 10mg | 52.00 € | ||
| 50mg | 93.00 € | ||
| 100mg | 107.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
ESI-09
CAS:263707-16-0
ESI-09 is a new-typel noncyclic nucleotide EPAC antagonist.The IC50 values of ESI-09 for EPAC1 and …
Formula:
C16H15ClN4O2
Purity:
98.48% - 99.57%
Color and Shape:
Solid
Molecular weight:
330.77
Ref: TM-T2244
| 2mg | 41.00 € | ||
| 5mg | 61.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 297.00 € | ||
| 100mg | 448.00 € | ||
| 1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
ESI 09
Controlled ProductCAS:263707-16-0
Applications ESI 09 acts as an EPAC inhibitor, preventing EPAC-mediated insulin release form β-pancreatic cells. …
Formula:
C16H15ClN4O2
Color and Shape:
Neat
Molecular weight:
330.769
Ref: TR-E658950
| 5mg | 142.00 € | ||
| 10mg | 236.00 € | ||
| 25mg | 446.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Ref: 10-F547227
| 1mg | 32.00 € | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
ESI-09
CAS:263707-16-0
ESI-09 is a novel drug candidate that has been shown to have synergistic effects with …
Formula:
C16H15ClN4O2
Purity:
Min. 95%
Molecular weight:
330.77 g/mol
Ref: 3D-NKA70716
| 5mg | 385.00 € | ||
| 50mg | 1,535.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
